At Reviva we are focused on developing a drug that targets both the serotonin and dopamine receptor signaling systems to more effectively treat schizophrenia and its comorbid symptoms.” ...
Among a plethora of factors, impaired activity of the serotonin receptors in the reward system underlies the ability of animals to self-impose food restriction, and the transition from under- to ...